SEC Form 4 · accession 0001127602-15-027614
UNITED THERAPEUTICS Corp · UTHR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Martine A Rothblatt
Officer — Chairman & Co-CEO · Director
Period of report
Sep 23, 2015
Accepted (ET)
Sep 24, 2015 · 4:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001082554
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 23, 2015 | M | 2,211 | $63.22 | A | 2,451 | D | |
| Common StockF2 | Sep 23, 2015 | S | 800 | $141.2333 | D | 1,651 | D | |
| Common StockF3 | Sep 23, 2015 | S | 911 | $141.8986 | D | 740 | D | |
| Common StockF4 | Sep 23, 2015 | S | 200 | $142.755 | D | 540 | D | |
| Common StockF5 | Sep 23, 2015 | S | 300 | $144.2167 | D | 240 | D | |
| Common Stock | holding | — | — | — | 166 | I | By Spouse | |
| Common Stock | holding | — | — | — | 625,031 | I | By Trusts |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options | $63.22 | Sep 23, 2015 | M | 2,211 | D | Dec 31, 2010 | Dec 31, 2020 | Common Stock | 2,211 | 378,100 | D |
| Stock OptionsF6 | $30.75 | holding | — | — | — | Dec 26, 2009 | Dec 31, 2017 | Common Stock | 371,614 | 371,614 | D |
| Stock OptionsF7 | $34.56 | holding | — | — | — | Dec 30, 2005 | Dec 30, 2015 | Common Stock | 37,050 | 37,050 | D |
Explanation of responses
- F1This exercise of stock options and corresponding sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.
- F2This transaction was executed in multiple trades at prices ranging from $140.44 to $141.43. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3This transaction was executed in multiple trades at prices ranging from $141.62 to $142.40. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4This transaction was executed in multiple trades at prices ranging from $142.72 to $142.79. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5This transaction was executed in multiple trades at prices ranging from $144.15 to $144.30. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F6Adjusted downward to reflect the exercise and sale of 5,547 shares on June 11, 2015, which was initially reported in error as the exercise of 5,547 options granted to the reporting person on December 30, 2005.
- F7Adjusted upward to reflect the exercise and sale of 5,547 shares on June 11, 2015 from the stock option granted on December 31, 2007, which was initially reported in error as the exercise of 5,547 options granted to the reporting person on December 30, 2005